| Bempedoic Acid (ETC-1002) A Current Review |
12 |
| Hypertensive Disorders of Pregnancy |
8 |
| Causal Effect of Lipids and Lipoproteins on Atherosclerosis Lessons from Genomic Studies |
8 |
| Cardiotoxicity of Immune Therapy |
7 |
| Blunt Cardiac Trauma Review |
7 |
| Cardiogenic Shock |
6 |
| Critical Care of the Post-Cardiac Arrest Patient |
6 |
| Pathophysiology of Atrial Fibrillation and Heart Failure: Dangerous Interactions |
6 |
| Epidemiology of Atrial Fibrillation and Heart Failure A Growing and Important Problem |
6 |
| Trastuzumab-Induced Cardiomyopathy |
6 |
| Cardiorenal Syndrome Pathophysiology |
6 |
| High-Density Lipoproteins Effects on Vascular Function and Role in the Immune Response |
6 |
| Management of Refractory Ventricular Fibrillation (Prehospital and Emergency Department) |
5 |
| Emerging and Future Technologies in Out-of-Hospital Cardiac Arrest Care |
5 |
| Cardiac Magnetic Resonance for Diagnosis and Risk Stratification |
5 |
| Surgical Myectomy Subaortic, Midventricular, and Apical |
5 |
| Cardiovascular Toxicities in Pediatric Cancer Survivors |
4 |
| Evaluation of Chest Pain and Acute Coronary Syndromes |
4 |
| Multidisciplinary Management of the Post-Cardiac Arrest Patient |
4 |
| Genetic Testing and Counseling for Hypertrophic Cardiomyopathy |
4 |
| Temporary Circulatory Support and Extracorporeal Membrane Oxygenation |
4 |
| Advanced Heart Failure Management and Transplantation |
4 |
| Continuous-Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding |
4 |
| Statin Intolerance Some Practical Hints |
4 |
| Triglyceride-Rich Lipoproteins |
4 |
| Antithrombotic Strategies and Device Thrombosis |
3 |
| Acute Kidney Injury, Heart Failure, and Health Outcomes |
3 |
| Hypertensive Emergencies A Review of Common Presentations and Treatment Options |
3 |
| Impact of Lipoproteins on Atherobiology Emerging Insights |
3 |
| Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic? |
3 |
| Cholesteryl Ester Transfer Protein Inhibitors as Agents to Reduce Coronary Heart Disease Risk |
3 |
| Fluoropyrimidine-Associated Cardiotoxicity |
3 |
| Ventricular Assist Device Infections |
3 |
| Approach to Surgery for Cardiac Tumors Primary Simple, Primary Complex, and Secondary |
3 |
| Carcinoid Heart Disease A Guide for Clinicians |
3 |
| Arrhythmogenic Anticancer Drugs in Cardio-Oncology |
2 |
| Role of Cardiovascular Biomarkers in the Risk Stratification, Monitoring, and Management of Patients with Cancer |
2 |
| Cardiac Biomarkers in Emergency Care |
2 |
| Non-ST-Segment Acute Coronary Syndromes |
2 |
| Novel Ablation Approaches for Challenging Atrial Fibrillation Cases (Mapping, Irrigation, and Catheters) |
2 |
| Acute Myopericardial Syndromes |
2 |
| Ventricular Arrhythmias |
2 |
| Cardiopulmonary Resuscitation Quality Issues |
2 |
| Double Sequential Defibrillation |
2 |
| Echocardiography in the Diagnosis and Management of Hypertrophic Cardiomyopathy |
2 |
| Anthracycline Cardiotoxicity It Is Possible to Teach an Old Dog Some New Tricks |
2 |
| MRI of Cardiotoxicity |
2 |
| Cardiomyopathy Prevention in Cancer Patients |
2 |
| Echocardiography Imaging of Cardiotoxicity |
2 |
| Impact of Mechanical Circulatory Support on Posttransplant Outcomes |
2 |
